Heterocyclic inhibitors of ATR kinase
The present disclosure relates to heterocyclic compounds and methods which inhibit ATR kinase to treat or prevent cancer.
Board of Regents, The University of Texas System ChemPartner Corporation
A A C C
A61P A61K C07D C07D
inventional inventional inventional inventional
Michael Garrett Christopher Lawrence Philip Sarah Suyambu Kesava Vijayan Maria Emilia Zhijun David
Johnson Carroll Jones Lively Ramaswamy Di Francesco Kang Lapointe